Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Hereditary Angioedema Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4448539
  • 113 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Hereditary Angioedema in recent years and the growth of consumers' demand is expected to drive the global Hereditary Angioedema market.

Geographically, the global Hereditary Angioedema market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Hereditary Angioedema market in North America.

Significant participants active in the global Hereditary Angioedema market include: Ionis Pharmaceuticals, Teva Pharmaceutical Industries, Pharming Group, CSL, ioCryst Pharmaceuticals, Cipla, Inc., Merck & Co., Inc., iBio, Shire, Sanofi N.V....

Global Hereditary Angioedema Market Segmentation:

Hereditary Angioedema market, by Hereditary Angioedema type:

Type I HAE

Type II HAE

Type III HAE

…

Hereditary Angioedema market, by Application:

Hospitals

clinics

Research centers

…

Hereditary Angioedema Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Hereditary Angioedema by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Hereditary Angioedema Market-Segmentation

4.1 By Type

4.1.1 Type I HAE

4.1.2 Type II HAE

4.1.3 Type III HAE

4.2 By End-User/Application Industry

4.2.1 Hospitals

4.2.2 clinics

4.2.3 Research centers

4.3 By Geography

4.3.1 North America Hereditary Angioedema Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Hereditary Angioedema Production from 2014-2020

4.3.1.2 North America Hereditary Angioedema Consumption from 2014-2020

4.3.1.3 North America Hereditary Angioedema Import and Export from 2014-2020

4.3.1.4 North America Hereditary Angioedema Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Hereditary Angioedema Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Hereditary Angioedema Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Hereditary Angioedema Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Hereditary Angioedema Production from 2014-2020

4.3.2.2 Europe Hereditary Angioedema Consumption from 2014-2020

4.3.2.3 Europe Hereditary Angioedema Import and Export from 2014-2020

4.3.2.4 Europe Hereditary Angioedema Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Hereditary Angioedema Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Hereditary Angioedema Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Hereditary Angioedema Production from 2014-2020

4.3.3.2 Asia-Pacific Hereditary Angioedema Consumption from 2014-2020

4.3.3.3 Asia-Pacific Hereditary Angioedema Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Hereditary Angioedema Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Hereditary Angioedema Production from 2014-2020

4.3.4.2 Latin America Hereditary Angioedema Consumption from 2014-2020

4.3.4.3 Latin America Hereditary Angioedema Import and Export from 2014-2020

4.3.4.4 Latin America Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Hereditary Angioedema Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Hereditary Angioedema Production from 2014-2020

4.3.5.2 Middle East & Africa Hereditary Angioedema Consumption from 2014-2020

4.3.5.3 Middle East & Africa Hereditary Angioedema Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Ionis Pharmaceuticals

5.1.1 Ionis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Ionis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Teva Pharmaceutical Industries

5.2.1 Teva Pharmaceutical Industries Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Teva Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Pharming Group

5.3.1 Pharming Group Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Pharming Group Sales, Growth Rate and Global Market Share from 2014-2020

5.4 CSL

5.4.1 CSL Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 CSL Sales, Growth Rate and Global Market Share from 2014-2020

5.5 ioCryst Pharmaceuticals

5.5.1 ioCryst Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 ioCryst Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Cipla, Inc.

5.6.1 Cipla, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Cipla, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Merck & Co., Inc.

5.7.1 Merck & Co., Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Merck & Co., Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.8 iBio

5.8.1 iBio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 iBio Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Shire

5.9.1 Shire Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Shire Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Sanofi N.V.

5.10.1 Sanofi N.V. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Sanofi N.V. Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Hereditary Angioedema Market from 2021-2026

7.1 Future Forecast of Global Hereditary Angioedema Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Hereditary Angioedema Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Hereditary Angioedema Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Hereditary Angioedema Market Value ($) and Growth Rate of Hereditary Angioedema from 2014-2026

Global Hereditary Angioedema Production and Growth Rate Segment by Product Types from 2014-2026F

Global Hereditary Angioedema Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Hereditary Angioedema Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Hereditary Angioedema Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Type I HAE of Hereditary Angioedema

Figure Type II HAE of Hereditary Angioedema

Figure Type III HAE of Hereditary Angioedema

Table Global Hereditary Angioedema Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Hereditary Angioedema Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Hospitals of Hereditary Angioedema

Figure clinics of Hereditary Angioedema

Figure Research centers of Hereditary Angioedema

Table Global Hereditary Angioedema Production Value ($) by Regions

Table Global Hereditary Angioedema Production Value Share by Regions

Table Global Hereditary Angioedema Production by Regions

Table Global Hereditary Angioedema Production Share by Regions

Table Global Hereditary Angioedema Consumption by Regions

Table Global Hereditary Angioedema Consumption Share by Regions

Figure North America Hereditary Angioedema Production and Growth Rate from 2014-2020

Figure North America Hereditary Angioedema Consumption and Growth Rate from 2014-2020

Table North America Hereditary Angioedema Import and Export from 2014-2020

Table North America Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

Table North America Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

Table North America Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

Figure Europe Hereditary Angioedema Production and Growth Rate from 2014-2020

Figure Europe Hereditary Angioedema Consumption and Growth Rate from 2014-2020

Table Europe Hereditary Angioedema Import and Export from 2014-2020

Table Europe Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

Table Europe Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

Table Europe Hereditary Angioedema Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Hereditary Angioedema Production and Growth Rate from 2014-2020

Figure Asia-Pacific Hereditary Angioedema Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Hereditary Angioedema Import and Export from 2014-2020

Table Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

Figure Latin America Hereditary Angioedema Production and Growth Rate from 2014-2020

Figure Latin America Hereditary Angioedema Consumption and Growth Rate from 2014-2020

Table Latin America Hereditary Angioedema Import and Export from 2014-2020

Table Latin America Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Hereditary Angioedema Production and Growth Rate from 2014-2020

Figure Middle East & Africa Hereditary Angioedema Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Hereditary Angioedema Import and Export from 2014-2020

Table Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Hereditary Angioedema Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Hereditary Angioedema Participants Value ($) and Market Share (%) in 2019

Table Ionis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Ionis Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Ionis Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pharming Group Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pharming Group Sales and Growth Rate from 2014-2020

Figure Pharming Group Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table CSL Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure CSL Sales and Growth Rate from 2014-2020

Figure CSL Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table ioCryst Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure ioCryst Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure ioCryst Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Cipla, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Cipla, Inc. Sales and Growth Rate from 2014-2020

Figure Cipla, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Merck & Co., Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Merck & Co., Inc. Sales and Growth Rate from 2014-2020

Figure Merck & Co., Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table iBio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure iBio Sales and Growth Rate from 2014-2020

Figure iBio Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Shire Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Shire Sales and Growth Rate from 2014-2020

Figure Shire Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sanofi N.V. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sanofi N.V. Sales and Growth Rate from 2014-2020

Figure Sanofi N.V. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Hereditary Angioedema Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Hereditary Angioedema Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Hereditary Angioedema Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Hereditary Angioedema Production and Growth Rate Forecast by Types (2021-2026)

Table Global Hereditary Angioedema Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390